Nicole Anderle

Areas of activity

Development of patient-derived preclinical tumor models, immuno-oncology with focus on autologous T cells, macrophages and dendritic cells

Stages of career

09/2018 - Present   Doktorandin, Tumorbiologie, NMI

08/2017 - 10/2017   Research Scholar, California Pacific Medical Center Research Institute, San Francisco

05/2016 - 09/2016   Research Intern, Tumorbiologie, NMI

2014 - 2018               Molecular Cell Biology and Immunology (Master of Science),                                                                                       Eberhard Karls Universität Tübingen

2012 - 2014               Biology (Bachelor of Science), Universität Hohenheim
Nicole Anderle
Scientist Tumor Biology
M.Sc.Molekulare Zellbiologie und Immunologie

Publications

  • Argyrin F Treatment-Induced Vulnerabilities Lead to a Novel Combination Therapy in Experimental Glioma
    Walter B, Canjuga D, Yüz S, Ghosh M, Bozko P, Przystal J, Govindarajan P, Anderle N, Keller AL, Tatagiba M, Schenke-Layland K, Rammensee HG, Stevanovic S, Malek N P, Schmees C, and TabatabaiG
    DOI: 10.1002/adtp.202100078
  • Generation and characterization of the human induced pluripotent stem cell line NMIi010-A from peripheral blood mononuclear cells of a healthy 49–year old male individual
    Keller AK, Binner A, Breitmeyer R, Vogel S, Anderle N, Rothbauer U, Schenke-Layland K, Schmees C
    Stem Cell Research Volume 54, July 2021, 102427, https://doi.org/10.1016/j.scr.2021.102427
  • Generation and characterization of the human induced pluripotent stem cell line NMIi010-A from peripheral blood mononuclear cells of a healthy 49–year old male individual
    Keller AL, Binner A, Breitmeyer R, Vogel S, Anderle N, Rothbauer U, Schenke-Layland K, Schmees C
    tem Cell Res. 2021 Jul;54:102427. doi: 10.1016/j.scr.2021.102427. Epub 2021 Jun 11. PMID: 34139596.
  • Targeting CSF1R Alone or in Combination with PD1 in Experimental Glioma
    Przystal JM, Becker H, Canjuga C, Tsiami F, Anderle N, Keller A, Pohl A, Ries CH, Schmittnaegel M, Korinetska N, Koch M, Schittenhelm J, Tatagiba M, Schmees C, Beck SC, Tabatabai G
    Cancers 2021, 13(10), 2400; https://doi.org/10.3390/cancers13102400
Go back